کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2100588 | 1083010 | 2006 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
How good is allogeneic transplantation for high-risk patients with AML?
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
Patients with acute myeloid leukemia (AML) may differ significantly in their response to therapy and long-term outcome. A number of risk factors have been identified that characterize patients at diagnosis as well as during their clinical course. At diagnosis these parameters include age, cytogenetic configuration, hemopoietic elements, and a previous history of myelodysplasia or cytoreductive therapy for a preexisting malignancy. They are complemented by the response to induction therapy and subsequent treatments as well as by the duration of response. More recently, gene expression profiling of leukemic cells has added a new dimension to simultaneously assess biological risk factors that may ultimately lead to individualization of therapy. This presentation will review data to address the question of whether or not allogeneic transplants are effective in the management of patients with AML presenting with adverse cytogenetics and older age, showing a poor response to induction therapy, and relapsing after achieving a remission.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Best Practice & Research Clinical Haematology - Volume 19, Issue 2, June 2006, Pages 329-332
Journal: Best Practice & Research Clinical Haematology - Volume 19, Issue 2, June 2006, Pages 329-332
نویسندگان
Hans A. (Professor of Medicine, Director BMT Program),